Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction

Emanuel Zitt; Denis Fouque; Stefan H Jacobson; Fabio Malberti; Miroslav Ryba; Pablo Ureña; Marianne Rix; Bastian Dehmel; Nick Manamley; Marc Vervloet

doi:10.1093/ckj/sft026

Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction

Emanuel Zitt, Denis Fouque, Stefan H Jacobson, Fabio Malberti, Miroslav Ryba, Pablo Ureña, Marianne Rix, Bastian Dehmel, Nick Manamley, Marc Vervloet

23 Citations (Scopus)

Abstract

The calcimimetic cinacalcet lowers parathyroid hormone (PTH), calcium (Ca) and phosphorus (P) in dialysis patients with secondary hyperparathyroidism (SHPT). We explored serum P changes in dialysis patients treated with cinacalcet, while controlling for vitamin D sterol and phosphate binder (PB) changes, based on data from the pan-European observational study ECHO.

Original language	English
Journal	Clinical kidney journal
Volume	6
Issue number	3
Pages (from-to)	287-294
Number of pages	8
ISSN	2048-8505
DOIs	https://doi.org/10.1093/ckj/sft026
Publication status	Published - Jun 2013

Access to Document

10.1093/ckj/sft026

Cite this

@article{98a22b2bdf084df6982ebb5c432802df,

title = "Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction",

abstract = "The calcimimetic cinacalcet lowers parathyroid hormone (PTH), calcium (Ca) and phosphorus (P) in dialysis patients with secondary hyperparathyroidism (SHPT). We explored serum P changes in dialysis patients treated with cinacalcet, while controlling for vitamin D sterol and phosphate binder (PB) changes, based on data from the pan-European observational study ECHO.",

author = "Emanuel Zitt and Denis Fouque and Jacobson, \{Stefan H\} and Fabio Malberti and Miroslav Ryba and Pablo Ure{\~n}a and Marianne Rix and Bastian Dehmel and Nick Manamley and Marc Vervloet",

year = "2013",

month = jun,

doi = "10.1093/ckj/sft026",

language = "English",

volume = "6",

pages = "287--294",

journal = "Clinical kidney journal",

issn = "2048-8505",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction

AU - Zitt, Emanuel

AU - Fouque, Denis

AU - Jacobson, Stefan H

AU - Malberti, Fabio

AU - Ryba, Miroslav

AU - Ureña, Pablo

AU - Rix, Marianne

AU - Dehmel, Bastian

AU - Manamley, Nick

AU - Vervloet, Marc

PY - 2013/6

Y1 - 2013/6

N2 - The calcimimetic cinacalcet lowers parathyroid hormone (PTH), calcium (Ca) and phosphorus (P) in dialysis patients with secondary hyperparathyroidism (SHPT). We explored serum P changes in dialysis patients treated with cinacalcet, while controlling for vitamin D sterol and phosphate binder (PB) changes, based on data from the pan-European observational study ECHO.

AB - The calcimimetic cinacalcet lowers parathyroid hormone (PTH), calcium (Ca) and phosphorus (P) in dialysis patients with secondary hyperparathyroidism (SHPT). We explored serum P changes in dialysis patients treated with cinacalcet, while controlling for vitamin D sterol and phosphate binder (PB) changes, based on data from the pan-European observational study ECHO.

UR - https://www.scopus.com/pages/publications/84878541059

U2 - 10.1093/ckj/sft026

DO - 10.1093/ckj/sft026

M3 - Journal article

C2 - 23717787

SN - 2048-8505

VL - 6

SP - 287

EP - 294

JO - Clinical kidney journal

JF - Clinical kidney journal

IS - 3

ER -

Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction

Abstract

Access to Document

Other files and links

Fingerprint

Cite this